Behavioral: clinical characteristics of ams patients (DrugBank: -)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
17 | Multiple system atrophy | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04250493 (ClinicalTrials.gov) | October 28, 2020 | 29/1/2020 | Insulin Resistance in Multiple System Atrophy | Insulin Resistance in Multiple System Atrophy | Multiple System Atrophy | Biological: Homeostasis Model Assessment of insulin resistance (HOMA);Behavioral: MOntreal Cognitive Assessment (MoCA);Behavioral: Clinical characteristics of AMS patients;Procedure: Brain Magnetic Resonance Imaging (MRI);Biological: Blood sampling | University Hospital, Bordeaux | Université de Bordeaux;Labex Brain;Centre National de la Recherche Scientifique, France | Recruiting | 30 Years | N/A | All | 124 | N/A | France |